GAITHERSBURG, Md., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company will release financial results for the three and six months ended September 30, 2010, following the close of the market on Wednesday, November 10, 2010.
